1 0

    FDA: Epidiolex Scheduling Recommendation & DEA Letter (2018)

    FDA: Epidiolex Scheduling Recommendation & DEA Letter (2018)

    $89.00 USD
    $89.00 USD
    Sale Sold out
    Request Content: HHS medical and scientific evaluation and scheduling recommendation for: Epidiolex formulation – Including updates and DEA letter dated June 13, 2018
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details